SJOGREN DISEASE

Clinical trials for SJOGREN DISEASE explained in plain language.

Never miss a new study

Get alerted when new SJOGREN DISEASE trials appear

Sign up with your email to follow new studies for SJOGREN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

New shot could tame Sjögren's Flare-Ups

Disease control Ongoing

This Phase 2 trial tests whether sibeprenlimab, a biologic drug given as a shot every 4 weeks, can reduce disease activity and symptoms in people with Sjögren's disease. About 83 adults with moderate-to-active disease will receive either the drug or a placebo, added to their usua…

Matched conditions: SJOGREN DISEASE

Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC

SJOGREN DISEASE

Get alerted when new SJOGREN DISEASE trials appear

New shot could tame Sjögren's Flare-Ups